# Endovascular Treatment With Versus Without Intravenous rhTNK-tPA in Stroke

Study · id `cardio:ct-nct04733742` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04733742](<https://clinicaltrials.gov/study/NCT04733742>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04733742

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 550 participants.

## Technical summary

Registry record NCT04733742. Randomized; single masking; primary purpose treatment. Start 2022-05-09 (actual); primary completion 2024-12-16 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2/3
- Enrolled: 550 participants (enrolled count; ClinicalTrials.gov record NCT04733742, source copy `cardio:ctgov-nct04733742-2025-04-03`, retrieved 2026-10-26)
- Started: 2022-05-09 (actual) (ClinicalTrials.gov record NCT04733742, source copy `cardio:ctgov-nct04733742-2025-04-03`, retrieved 2026-10-26)
- Primary completion: 2024-12-16 (actual) (ClinicalTrials.gov record NCT04733742, source copy `cardio:ctgov-nct04733742-2025-04-03`, retrieved 2026-10-26)
- Completion: 2025-02-07 (actual) (ClinicalTrials.gov record NCT04733742, source copy `cardio:ctgov-nct04733742-2025-04-03`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04733742, source copy `cardio:ctgov-nct04733742-2025-04-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04733742-2025-04-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Endovascular Treatment With Versus Without Intravenous rhTNK-tPA in Stroke
- Acronym: BRIDGE-TNK
- Condition: Stroke, Acute
- Condition: Stroke, Ischemic
- Intervention (Drug): rhTNK-tPA
- Intervention (Other): Endovascular treatment
- Lead sponsor: Xinqiao Hospital of Chongqing
- Lead sponsor class: OTHER
- Collaborator: CSPC RECOMGEN PHARMACEUTICAL (GUANGZHOU) CO.,LTD
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Xinqiao Hospital of Chongqing (`cardio:org-xinqiao-hospital-of-chongqing`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Intravenous Tenecteplase before Thrombectomy in Stroke (`cardio:pubmed-40396577`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of Baseline ASPECTS on Tenecteplase Efficacy Before Thrombectomy in Acute Large-Vessel Occlusion Stroke: A Post Hoc Analysis of the BRIDGE-TNK Randomized Trial (`cardio:pubmed-42623571`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: b81f0ad0656fd9fe02390b8acb9f53b76fbca1b32f03288090e80937e56651ff
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
